About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
Previous Close | $219.55 | Open | $222.15 |
Volume | 6.99M | Market Cap | 31.826B |
Yield | Last Dividend |
4 takeaways from Teladoc???s earnings - ... | 02/26/21 |
After a year of record growth, Teladoc set expectations for limited growth in its paid memberships and visits in 2021. But the company still sees long... |
$74 billion health insurer Cigna is buyi... | 02/26/21 |
Summary List Placement Cigna, a health insurer with a market cap of $74 billion, is buying telehealth company MDLive, the companies said Friday. The t... |
Canaccord Genuity Stick to Their Buy Rat... | 02/25/21 |
Canaccord Genuity Stick to Their Buy Rating for Teladoc |
Oppenheimer Stick to Their Buy Rating fo... | 02/24/21 |
Oppenheimer Stick to Their Buy Rating for Teladoc |
Teladoc Lower After Posting Wider-Than-E... | 02/24/21 |
Teladoc's shares fell after the telemedicine provider posted a wider-than-expected fourth-quarter loss. |
Teladoc shares tumble 7% on Q4 results | 02/24/21 |
Teladoc Health Inc.'s undefined shares were initially down 7% in extended trading Wednesday after the virtual healthcare company reported fiscal??? |
Will Higher Business Volumes Aid Teladoc... | 02/22/21 |
Stocks Analysis by Zacks Investment Research covering: Medtronic PLC, Amedisys Inc, Lexicon Pharmaceuticals Inc, Teladoc Inc. Read Zacks Investment Re... |
MIS signs deal with InTouch Health to es... | 02/21/21 |
Riyadh ??? Mubasher: Al Moammar Information Systems (MIS) has signed an agreement with InTouch Health Company, part of Teladoc Health, a global leader... |
ARK Innovation ETF Holdings: Tesla, Invi... | 02/18/21 |
ARK runs five exchange-traded funds, including ARK Innovation ETF, and the management invests in companies they believe will change the world. |
Just Had My First Teladoc Appointment: I... | 02/17/21 |
Just Had My First Teladoc Appointment: Is the Rally Over????CROX |
Teladoc Health (TDOC) Set to Announce Ea... | 02/17/21 |
Teladoc Health (NYSE:TDOC) is set to issue its quarterly earnings data after the market closes on Wednesday, February 24th. Analysts expect the compan... |
Thematic ETFs boom, drawing punters and ... | 02/12/21 |
LONDON: From cat food to cannabis, it's boom time for quirky ETFs offering the chance to punt on niche themes in fast-growth sectors, but their huge g... |
Healthcare hedge fund Rhenman still buoy... | 02/09/21 |
Healthcare hedge fund Rhenman still buoyant on sector, as flagship strategy advances in January Submitted By Hugh Leask | 09/02/2021 - 4:32pm The heal... |
Jim Cramer: What's Winning Is the Techno... | 02/09/21 |
Jim Cramer: What's Winning Is the Technology of Replacement???TDOC |
As thousands of doctors??? offices shutt... | 02/08/21 |
Like many other physicians, Dr. Sandra Esparza and her husband Ramon closed their 17-year old primary care practice in December. It had always been a ... |
FXNEWS24 |Teladoc (TDOC) Gains As Market... | 01/30/21 |
Teladoc (TDOC) Gains As Market Dips: What You Should Know | UK Stocks, Forex, Commodities, Crypto, Live Market News- Daily Forex News |
Insider Selling: Teladoc Health, Inc. (N... | 01/30/21 |
Teladoc Health, Inc. (NYSE:TDOC) insider Yulun Wang sold 8,261 shares of the company???s stock in a transaction dated Monday, January 25th. The stock ... |
Moda Health and Teladoc Health Partner t... | 01/27/21 |
PORTLAND, Ore.--(BUSINESS WIRE)--Moda Health today announced a pioneering collaboration with Teladoc Health that will bring the industry leading Livon... |
Insider Selling: Teladoc Health, Inc. (N... | 01/25/21 |
Teladoc Health, Inc. (NYSE:TDOC) insider Yulun Wang sold 8,000 shares of the business???s stock in a transaction dated Friday, January 22nd. The share... |
MedPAC may recommend pilot coverage for ... | 01/25/21 |
The impetus to provide more Medicare coverage of telehealth may prove irresistible, but the Medicare Payment Advisory Commission (MedPAC) has some res... |
STAT+: How Teladoc is teeing itself up t... | 01/21/21 |
"We are still just scratching the surface,??? Teladoc CEO Jason Gorevic said. ???There is a tremendous opportunity to expand our membership.??? |
Barclays Stick to Their Hold Rating for ... | 01/17/21 |
Barclays Stick to Their Hold Rating for Teladoc |
RBC Capital Stick to Their Buy Rating fo... | 01/14/21 |
RBC Capital Stick to Their Buy Rating for Teladoc |
Teladoc (TDOC) and Dexcom Offer New Solu... | 01/12/21 |
Teladoc (TDOC) and Dexcom jointly provide solutions for patients with Type 2 diabetes, a common lifestyle-induced malady. |
RBC shared its top 6 digital health pick... | 01/11/21 |
Summary List Placement The digital health industry gained momentum in 2020 as the pandemic forced healthcare providers to shift to using online platfo... |
Here are some of RBC's top stock picks f... | 01/09/21 |
RBC gave its top stock picks for 2021, which include names like Teladoc and Nike. |
Jason N. Gorevic Sells 30,000 Shares of ... | 01/08/21 |
Teladoc Health, Inc. (NYSE:TDOC) CEO Jason N. Gorevic sold 30,000 shares of the business???s stock in a transaction that occurred on Tuesday, January ... |
Stocks making the biggest moves midday: ... | 01/07/21 |
Take a look at the stocks making notable moves in midday trading. |
Online Doctor Consultation Market Growth... | 01/07/21 |
The Global Online Doctor Consultation Market Report 2026 is a professional and in-depth study on the current state of the Online Doctor Consultation M... |
Teladoc Health, Inc. (NYSE:TDOC) Insider... | 01/06/21 |
Teladoc Health, Inc. (NYSE:TDOC) insider Adam C. Vandervoort sold 2,529 shares of the company???s stock in a transaction dated Monday, January 4th. Th... |
Strong Buy rating | 02/26/21 |
Credit Suisse maintains Outperform rating and raises Price Target from $296.00 to $300.00 |
Strong Buy rating | 02/25/21 |
KeyBanc maintains Overweight rating and raises Price Target from $245.00 to $270.00 |
Strong Buy rating | 02/25/21 |
SVB Leerink maintains Outperform rating and raises Price Target from $256.00 to $266.00 |
Strong Buy rating | 02/25/21 |
Piper Sandler maintains Overweight rating and lowers Price Target from $305.00 to $291.00 |
Buy rating | 02/25/21 |
Deutsche Bank maintains Buy rating and raises Price Target from $244.00 to $263.00 |
Hold rating | 02/25/21 |
Jefferies maintains Hold rating and lowers Price Target from $264.00 to $248.00 |
Strong Buy rating | 02/25/21 |
Oppenheimer maintains Outperform rating and raises Price Target from $250.00 to $270.00 |
Buy rating | 02/25/21 |
DA Davidson maintains Buy rating and raises Price Target from $260.00 to $275.00 |
Buy rating | 01/07/21 |
BTIG initiates coverage with Buy rating and announces Price Target of $240.00 |
Hold rating | 12/22/20 |
Evercore ISI Group initiates coverage with In-Line rating and announces Price Target of $215.00 |
Hold rating | 12/04/20 |
Goldman Sachs initiates coverage with Neutral rating and announces Price Target of $206.00 |
Date | 2021-02-24 (AMC) | Est. (EPS/Rev.) | ($0.24)/ 378.41M |
Actual (EPS/Rev.) | $-0.27/ $383.32 M | EPS (TTM) | 0 |
Total Revenue | $1.3B | Total Liabilities | $2.1B |
Cost of Revenue | $2.5B | Total cash flow | $3.2 |
Total Assets | $29.98B |
% Insider | 12.52% | % Institutional | 76.43% |
Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
Service Name | Trader | % Success | |
---|---|---|---|
Stock_Options | alps | 92.00 % | Follow |
Tech Trades | Tech Trades | 81.00 % | Follow |
High Growth Stocks- Long only | Srini Donapati | 73.00 % | Follow |
Big Move Options | Michael Hurst | 71.00 % | Follow |
Momentum Stocks Only | Hao | 56.00 % | Subscribe |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.